Глава 308

Mellors JW et al: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167, 1996

Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. NEnglJMed 332:1181, 1995

Moore RD, Chaisson RE: Natural history of opportunistic diseases in an HIV-infected urban clinical cohort. Ann Intern Med 124:633, 1996

Nduati RWet al: Human immunodeficiency virus type 1-infected cells in breast milk: Association with immunosuppression and vitamin Adeficiency. J Infect Dis 172:1461, 1995

Oberlin E et al: The CXC chemokine receptor SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833, 1996

O'Brien WA et al: Changes in plasma HIV-1 RNA and CD4+ lymphocyte count and the risk of progression to AIDS. N Engl J Med 334:426, 1996

Pantaleo G et al: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332:209, 1995

Pantaleo G, Fauci AS: New concepts in the pathogenesis of HIV infection. Annu Rev Immunol 13:487, 1995

Pantaleo G et al: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355, 1993

Peckham C, Gibb D: Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 333:298, 1995

Perelson AS et al: HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582, 1996

Piatak M et al: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749, 1993

Price RW: Neurological complications of HIV infection. Lancet 348:445, 1996

Redfield RR et al: The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Med 314:131, 1986

Robertson DL et al: Recombination in HIV-1. Nature 374:124, 1995

Rosenberg PS: Scope of the AIDS epidemic in the United States. Science 270:1372, 1995

Samson M et al: Resistance to HIV-1 infection in Caucasian indi­viduals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722, 1996

Schacker Т et al: Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 125:257, 1996

Smith KJ et al: Cutaneous findings in HIV-1 positive patients: a 42-month prospective study. J Am Acad Dermatol 31:746, 1994

Sparano JA: Treatment of AIDS-related lymphomas. Curr Opin Oncol 7:442, 1995

Spector SA et al: Oral ganciclovir for the prevention of cytome-galovirus disease in persons with AIDS. NEnglJMed 334:1491,1996

Soca ACTG: Mortality in patients with the acquired immuno­deficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 326:213, 1992

Soto-Ramirez LE et al: HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 271:1291, 1996

Spira Al et al: Cellular targets of infection and route of viral dis­semination after an intravaginal inoculation of simian immunode­ficiency virus into rhesus macaques. J Exp Med 183:215, 1996

Stanley SK, Fauci AS: Т cell homeostasis in HIV infection: Part of the solution or part of the problem?. J Acquired Immune Defic Syndr HumRetrovirol6:142, 1993

Tindall B, Cooper DA: Primary HIV infection. Host responses and intervention strategies. AIDS 5:1, 1991

Walker CM et al: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563, 1986

Wei X et al: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117, 1995

Whalen С et al: Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Medl51:129, 1995

Zinkernagel RM et al: Immunology taught by viruses. Science 271:173, 1996

1